Results 121 to 130 of about 14,427,848 (200)

Correction: Required minimal protein domain of flower for synaptobrevin2 endocytosis in cytotoxic T cells. [PDF]

Cell Mol Life Sci
Ravichandran K, Schirra C, Urbansky K, Tu SM, Alawar N, Mannebach S, Krause E, Stevens D, Lancaster CRD, Flockerzi V, Rettig J, Chang HF, Becherer U.   +12 more
europepmc   +1 more source

Elevated Th1 and terminally differentiated cytotoxic T cells with suppressed Tc17 lymphocytes in lung tissue of advanced COPD and IPF patients undergoing lung transplantation. [PDF]

Front Immunol
Šarc I, Rijavec M, Dejanović L, Koren A, Zimmermann M, Ankersmit HJ, Korošec P.   +6 more
europepmc   +1 more source

Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patients. [PDF]

J Clin Invest
Staeger R, Tastanova A, Ghosh A, Winkelbeiner N, Shukla P, Kolm I, Turko P, Benlahrech A, Harper J, Broomfield A, Camera A, Ambrosio M, Haunerdinger V, Cheng PF, Ramelyte E, Pham J, Kreutmair S, Becher B, Levesque MP, Dummer R, Meier-Schiesser B.   +20 more
europepmc   +1 more source

Tumor cell spheroid-induced suppression of primary human cytotoxic T cells as a scalable <i>in vitro</i> model of exhaustion. [PDF]

Immunother Adv
Alsubaiti A, Alamir H, Huynh L, Grant T, Aljohani A, Chou PH, Shi Y, Alismail M, Mason LR, Herman A, Bridgeman JS, Holland CJ, Wülfing C.   +12 more
europepmc   +1 more source

Development of potent HLA-A02:01-restricted peptide-based cytotoxic T-cells against SARS-CoV-2 infections in patients awaiting a kidney transplant. [PDF]

Front Immunol
Chang CC, Liu YN, Xu Z, Vasilescu ER, Li P, Ho EK, Li M, Husain SA, Bhagat G, Mohan S, Vlad G, Suciu-Foca N.   +11 more
europepmc   +1 more source

Required minimal protein domain of flower for synaptobrevin2 endocytosis in cytotoxic T cells. [PDF]

Cell Mol Life Sci
Ravichandran K, Schirra C, Urbansky K, Tu SM, Alawar N, Mannebach S, Krause E, Stevens D, Lancaster CRD, Flockerzi V, Rettig J, Chang HF, Becherer U.   +12 more
europepmc   +1 more source

CD19-ReTARG^TPR: A Novel Fusion Protein for Physiological Engagement of Anti-CMV Cytotoxic T Cells Against CD19-Expressing Malignancies. [PDF]

Cancers (Basel)
van Wijngaarden AP, Britsch I, Peipp M, Samplonius DF, Helfrich W.   +4 more
europepmc   +1 more source

GZM^hi Cytotoxic T Cells: A Key Discovery in Fibrotic Hypersensitivity Pneumonitis. [PDF]

Am J Respir Crit Care Med
Karampitsakos T, Herazo-Maya JD.
europepmc   +1 more source

Immunomodulatory nanoparticles activate cytotoxic T cells for enhancement of the effect of cancer immunotherapy. [PDF]

Nanoscale
Wells K, Liu T, Zhu L, Yang L.
europepmc   +1 more source

ABIN1 is a negative regulator of effector functions in cytotoxic T cells. [PDF]

EMBO Rep
Janusova S, Paprckova D, Michalik J, Uleri V, Drobek A, Salyova E, Chorfi L, Neuwirth A, Andreyeva A, Prochazka J, Sedlacek R, Draber P, Stepanek O.   +12 more
europepmc   +1 more source